4//SEC Filing
MURRAY RICHARD /CA/ 4
Accession 0001640455-22-000010
CIK 0001640455other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 8:57 PM ET
Size
7.0 KB
Accession
0001640455-22-000010
Insider Transaction Report
Form 4
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
- Sale
Common Stock
2022-01-07$7.30/sh−13,370$97,601→ 209,501 total - Sale
Common Stock
2022-01-10$6.65/sh−23,924$159,095→ 185,577 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Represents the weighted average share price of an aggregate total of 13,370 shares sold in the price range of $7.03 to $7.65 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 23,924 shares sold in the price range of $6.57 to $6.90 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001242935
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 8:57 PM ET
- Size
- 7.0 KB